Tulane Lakeside Hospital
- Research works
- 24 ▼ 5% vs 2013–17
- Citations
- 962 40.1 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 11% world 28%
Not ranked overall: Tulane Lakeside Hospital is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Tulane Lakeside Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Treatment, Risk Assessment, Pain Management, Immune Response, Contact Allergy and Skin Sensitization.
- Urachal Carcinoma
- Primary Urethral Carcinoma
- Mycobacterium avium
- Genetic Mutations
- Archaeoastronomy
- Vaccine Administration
- Skin Sensitization
- Immune Response
- Risk Assessment
- Diagnosis
- Epidemiology
- Treatment
- Contact Allergy
- Pain Management
- Intramuscular Injections
- Management
- Cultural Landscapes
- HLA-B*5701
- Nontuberculous Mycobacteria
- Stevens-Johnson Syndrome
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 20 words, with their numbers
- Epidemiology5▲ 5.0×15 topics
- Diagnosis3▲ 12×8 topics
- Treatment2▲ 7.5×7 topics
- Risk Assessment2▲ 12×2 topics
- Contact Allergy1▲ 206×1 topic
- Immune Response1▲ 9.8×5 topics
- Pain Management1▲ 26×2 topics
- Skin Sensitization1▲ 206×1 topic
- Intramuscular Injections1▲ 737×1 topic
- Vaccine Administration1▲ 737×1 topic
- Management1▲ 6.3×4 topics
- Archaeoastronomy1▲ 384×1 topic
- Cultural Landscapes1▲ 188×1 topic
- Genetic Mutations1▲ 8.2×6 topics
- HLA-B*57011▲ 191×1 topic
- Mycobacterium avium1▲ 92×1 topic
- Nontuberculous Mycobacteria1▲ 92×1 topic
- Primary Urethral Carcinoma1▲ 183×1 topic
- Stevens-Johnson Syndrome1▲ 191×1 topic
- Urachal Carcinoma1▲ 183×1 topic
Which research topics does Tulane Lakeside Hospital publish most on?
By volume in 2022–2025: Systemic Lupus Erythematosus Research, Inflammasome and immune disorders, Neuroendocrine Tumor Research Advances and Gastrointestinal Tumor Research and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Systemic Lupus Erythematosus Research Rheumatology 0 works
- 2 Inflammasome and immune disorders Molecular Biology 0 works
- 3 Neuroendocrine Tumor Research Advances Epidemiology 0 works
- 4 Gastrointestinal Tumor Research and Treatment Gastroenterology 0 works
- 5 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
- 6 interferon and immune responses Immunology 0 works
- 7 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 0 works
- 8 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 9 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
- 10 Intestinal Malrotation and Obstruction Disorders Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tulane Lakeside Hospital's research output changed?
Output in 2018–2022 was 5% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Metairie
- Littoral Research Group (United States)
- East Jefferson General Hospital
- Universal Sensors (United States)
- Louisiana Organ Procurement Agency
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.